Bacterial enzyme converts type A blood to universal type O

After years of limited success, researchers have found a way to convert type A blood cells into the more universal type O by leveraging human gut bacteria, according to a report in the magazine Science.

Type O blood is considered universal because it lacks certain antigens that would otherwise cause a person’s immune system to reject blood cells of a different type. It’s often considered in high demand and short supply, so if scientists were able to strip type A cells of their defining sugars, effectively neutralizing them, that blood could be transfused between bodies without the risk of rejection or serious complications.

By analyzing the DNA in a human stool sample, researchers at the University of British Columbia in Vancouver, Canada, found enzymes derived from a gut bacterium called Flavonifractor plautii were capable of scrubbing type A cells’ A-defining sugars, redefining the blood as type O.

“This is a first, and if these data can be replicated, it is certainly a major advance,” Harvey Klein, a blood transfusion expert who wasn’t involved in the study, told Science.

According to the researchers, since type A blood makes up just under one-third of the supply in the U.S., this innovation could nearly double the availability of universal donor blood.

Read the full story below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.